Skip to main content

Why To Invest In INDIAN Healthcare?

SIZE
Healthcare delivery is one of the largest service-sector industries in India
Estimated revenue of about US$30 billion (FY 2006)
Industry growth at over 12% p.a. in the past four years
Large domestic market complemented by the inflow of medical tourists
Medical tourists have increased almost twenty-fold from 10,000 in 2000 to about 1,80,000–2,00,000 in 2006

STRUCTURE
The industry is fragmented with a large number of independent, privately-run hospital and healthcare centres
Private healthcare providers account for almost 70%-80% of the total spend
Government sector and corporate employers account for the rest
Private sector corporate entities like Apollo Hospitals, Wockhardt Hospitals and Fortis Healthcare have aggressive expansion plans
Indian hospitals are gaining reputation globally as ‘quality’ service providers
Many Indian hospitals have secured accreditation from the British Standards Institute and Joint Commission on Accreditation of Healthcare Organisations
NHS, UK has indicated India as a preferred destination for surgery.

POLICY
100% FDI is permitted for all health related services under the automatic route
Infrastructure status accorded to hospitals:
Lower tariffs and higher depreciation on medical equipment
Income-tax exemption for five years to hospitals in rural areas.

Top Private Healthcare Providers in India

Player Revenues (US$ million) Number of Hospitals Beds
Apollo Hospitals 212 (2007) 45 4,148
Wockhardt Hospitals 37 (2006) 8 1,390
Fortis Healthcare 30 (2007) 13 1,790
Manipal Group NA 16 5,659
Source: Company websites, Capitaline Database

OUTLOOK
The industry is expected to grow at 15% p.a. to US$60 billion by 2010
Medical tourism is expected to become a US$2 billion industry by 2010
Significant growth in healthcare BPO: Expected to become a US$4.5 billion industry by 2008

POTENTIAL
High growth domestic market arising from:
Increasing health awareness: Share in total private consumption expenditure has increased from 3.5% (1993-94) to 5.3% (2000-01).
Expected to increase further
Increasing penetration of Health insurance
Rapid growth in private sector companies owning and managing hospitals
High growth in medical tourism
Cost of comparable treatment is on average 1/8th to 1/5th of those in western countries
Opportunities exist in multiple segments along the value chain
Service Providers: Curative and preventive in primary, secondary and tertiary care
Diagnostics Services: Imaging and pathology labs
Infrastructure: Hospitals, Diagnostic centres
Health Insurance: Less than 10% of population is covered by health insurance. Medical Insurance premium income is expected to grow to US$3.8 billion by 2012
*44% growth in Health Insurance during 2006-2007
Healthcare BPO: Medical billing, disease coding, forms processing and claims adjudication
Training: Large opportunity for training doctors, managers, nurses and technicians
Investment opportunity of over US$25 billion by 2010

Source: IBEF, Indian Healthcare Foundation, India Country Commercial Guide 2002

Comments

Popular posts from this blog

Artificial Intelligence Policy and Governance in HEALTHCARE

  Artificial Intelligence has become the new frontier for digital transformation. Several  #digitalhealth  businesses of today rely on Machine Learning,  #AI  and other such technologies to make healthcare delivery more efficient and comprehensive. However, the efficient and responsible use of AI tools is an ongoing discussion and would mean culture, data management, technology shifts in the industry, and required up-grading and training professionals for better coordination. Hence, with the growing market potential and interest in AI, it is imperative to develop a thoughtthrough regulatory and legal framework on the adoption and use of AI. I have set forward a hypotheses to design a policy framework for AI technologies in my paper- "𝐀𝐫𝐭𝐢𝐟𝐢𝐜𝐢𝐚𝐥 𝐈𝐧𝐭𝐞𝐥𝐥𝐢𝐠𝐞𝐧𝐜𝐞 𝐢𝐧 𝐇𝐞𝐚𝐥𝐭𝐡 𝐏𝐨𝐥𝐢𝐜𝐲 – 𝐀 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞" last year https://lnkd.in/emi3XWwa cited further by "𝐓𝐡𝐞 𝐐𝐮𝐚𝐧𝐝𝐚𝐫𝐲 𝐢𝐧 𝐃𝐚𝐭𝐚 𝐏𝐫𝐨𝐭𝐞𝐜𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐑

Artificial intelligence and Technology for Dentistry

Have you heard of this company  ORCA Dental AI ? ORCA combines clinical expertise with machine learning and AI technologies to create diagnostic reports, treatment plan suggestions and smart clinical predictions. Good to learn about these innovations that benefit every stakeholder in the value chain. Recently,  VideaHealth  raised $20M to Expand AI-Based Diagnostics led by Spark Capital including existing investors Zetta Venture Partners. Among its many benefits to dentists and patients are: – A 31% increase in diagnosis rate for cavities and 26% increase in treatment plan value; – An increase in case acceptance by patients due to second opinions; – Automated workflows accelerate treatment planning and charting; Another company touting AI-powered dental care and practice management is  Overjet , which announced a $42.5 million Series B funding round in December months after it had scored $27 million in Series A funding.  Pearl  provides AI for dental images to assist in diagnosis. It l

Big Data Analytics- The Microscope and Telescope for Pharma/CRO

This article is produced in consultation with Industry experts, and KOLs in India and across the world and especially highlights how “Predictive Analytics algorithms” are poised to provide Useful Analytics to the Pharma industry.   In today’s highly competitive market, it is extremely important for contract research and manufacturers to have access to information that allows them to target the specific segments of the pharmaceutical and biotechnology industry that are looking to outsource the particular services they provide.  Understanding shifts in annual outsourcing budgets and spending can help CROs and CMOs to better position themselves for capturing business, particularly at a time when many – if not all – pharma and biotech companies are looking to cut costs and streamline operations.  As per a recent report by NiceInsights, Analytical Services, Clinical Research, and Clinical Monitoring will be the most demanded services over the next 12 to 18 months. For CROs and CMOs looki